Selectivity of omeprazole inhibition towards rat liver cytochromes P450

Xenobiotica

Volumn 27, Issue 1, 1997, Pages 49-58

  Zomorodi, K ^a,b   Houston, J B ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA NAPHTHOFLAVONE; CYTOCHROME P450 ISOENZYME; DEXAMETHASONE; DIAZEPAM; ETHOXYCOUMARIN; ETHOXYRESORUFIN; ETHYLMORPHINE; KETOCONAZOLE; OMEPRAZOLE; OMEPRAZOLE SULFONE; PENTOBARBITAL;

ANIMAL TISSUE; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME INHIBITION; IN VITRO STUDY; LIVER MICROSOME; MALE; NONHUMAN; RAT;

7-ALKOXYCOUMARIN O-DEALKYLASE; ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; DIAZEPAM; ETHYLMORPHINE-N-DEMETHYLASE; KETOCONAZOLE; MALE; MICROSOMES, LIVER; OMEPRAZOLE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTRATE SPECIFICITY;

ANIMALIA; STAPHYLOCOCCUS PHAGE 3A;

EID: 0031024089     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982597240758     Document Type: Article

References (29)

1. ANDERSSON, T., ANDRÉN, K., CEDERBERG, C., EDVARDSSON, G., HEGGELUND, A. and LUNDBORG, P. 1990a, Effect of omeprazole and cimetidine on plasma diazepam levels. European Journal of Clinical Pharmacology, 39, 51-54.
2. ANDERSSON, T., CEDERBERG, D., EDVARDSSON, G., HEGGELUND, A. and LUNDBORG, P., 1990b, Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolisers of omeprazole. Clinical Pharmacology and Therapeutics, 47, 79-85.
3. ANDERSSON, T., 1991, Omeprazole drug interaction studies. Clinical Pharmacokinetics, 21, 195-212.
4. BACHMANN, K. A., SULLIVAN, T. J., JAUREGUI, L., REESE, J. H., MILLER, K. and LEVINE, L., 1993, Absence of an inhibitory effect of omeprazole and nizatidine on phenytoin disposition, a marker of CYP2C activity. British Journal of Clinical Pharmacology, 36, 380-382.
5. BLOHMÉ, I., IDSTRÖM, J. P. and ANDERSSON, T., 1993, A study of interaction between omeprazole and cyclosporin in renal transplant patients. British Journal of Clinical Pharmacology, 35, 156-160.
6. BOOBIS, A. R., KAHN, G. C., WHYTE, C., BRODIE, M. J. and DAVIES, D. S. 1981, Biphasic O-deethylation of phenacetin and 7-ethoxycoumarin by human and rat liver microsomal fractions. Biochemical Pharmacology, 30, 2451-2456.
7. CHENERY, R. J., AYRTON, A., OLDHAM, H. G., NORMAN, S. J. and STANDRING, P., 1988, The interaction of omeprazole with rat liver cytochrome P450-mediated monooxygenase reactions in vitro and in vivo. Biochemical Pharmacology, 37, 1407-1414.
8. DIAZ, D., FABRE, I., DAUJAT, M., AUBERT, B. S., BORIES, P., MICHEL, H. and MAUREL, P., 1990, Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. Gastroenterology, 99, 737-747.
9. GUGLER, R. and JENSEN, J. C. 1985, Omeprazole inhibits oxidative drug metabolism. Gastroenterology, 89, 1235-1241.
10. HENRY, D. A., GERKENS, J. F., BRENT, P. J. and DOSEN, P. J., 1986, Omeprazole: effects on oxidative drug metabolism in the rat. Clinical and Experimental Pharmacology and Physiology, 13, 377-381.
11. HEUMAN, D. M., GALLAGHER, E. J., BARWICK, J. L., ELSHOURBAGY, N. A. and GUZELIAN, P. S., 1982, Immunochemical evidence for induction of a common form of hepatic cytochrome P450 in rats treated with pregnenolone 16-α-carbonitrile or other steroidal or non-steroidal agents. Molecular Pharmacology, 21, 753-760.
12. HOFFMANN, K.-J., 1986, Identification of the main urinary metabolites of omeprazole after an oral dose to rats and dogs. Drug Metabolism and Disposition, 14, 341-348.
13. KROMER, W., POSTIUS, S., RIEDEL, R., SIMON, W. A., HANAUER, G., BRAND, U., GÖNNE, S. and PARSONS, M. E., 1990, BY 1023/SK&F 96022 INN pantoprozole, a novel gastric proton pump inhibitor, potency inhibits acid secretion but lacks relevant cytochrome P450 interactions. Journal of Pharmacology and Experimental Therapeutics, 254, 129-135.
14. LAKE, B. G. and PAINE, A. J., 1983, Induction of hepatic cytochrome P450 and drug metabolism by metyrapone in the rat: relevance to its effects in rat-liver cell culture. Xenobiotica, 13, 725-730.
15. LAKE, B. G., 1987, Preparation and characterization of microsomal fragments for studies in xenobiotic metabolism. In Biochemical Toxicology : A Practical Approach, edited by K. Snell and B. Mullock (Washington: (RL), pp. 204-206.
16. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin-phenol reagent. Journal of Biological Chemistry, 193, 265-275.
17. LU, A. Y. H., SOMOGYI, A., WEST, S., KUNTZMAN, R. and CONNEY, A. H., 1972, Pregnenolone-16α-carbonitrile: a new type of inducer of drug-metabolizing enzymes. Archives of Biochemistry and Biophysics, 152, 457-462.
18. NEVILLE, C. F., NINOMIYA, S.-L., SHIMADA, N., KAMATAKI, T., IMAOKA, S. and FUNAE, Y., 1993, Characterisation of specific cytochrome P450 enzymes responsible for the metabolism of diazepam in hepatic microsomes of adult male rats. Biochemical Pharmacology, 45, 59-65.
19. REGÅRDH, C. G., GABRIELSSON, M., HOFFMANN, K.-J., LÖFBERG, I. and SKÅNBERG, I., 1985, Pharmacokinetics and metabolism of omeprazole in animals and man - an overview. Scandinavian Journal of Gastroenterology, 20, 79-94.
20. REILLY, P. E. B., THOMPSON, D. A., MASON, S. R. and HOOPER, W. D., 1990, Cytochrome P450IIIA enzymes in rat liver microsomes : involvement in C3-hydroxylation of diazepam and nordiazepam but not N-dealkylation of diazepam and temazepam. Molecular Pharmacology 37, 767-774.
21. 14C] omeprazole in humans. Drug Metabolism and Disposition, 17, 69-76.
22. SCHOULER, L., DUMAS, F., COUZIGOU, P., JANVIER, G., WINNOCK, S. and SARIC, J., 1991, Omeprazole-cyclosporin interaction. American Journal of Gastroenterology, 86, 1097.
23. +-ATPase inhibitor pantoprazole (BY1023/SK&F96022) interacts less with cytochrome P450 than omeprazole and lansoprazole. Biochemical Pharmacology, 42, 347-355.
24. SUTFIN, T., BALMER, K., BOSTRÖM, ERIKSSON, S., HÖGLUND, P. and PAULSEN, O., 1989, Stereoselective interaction of omeprazole with warfarin in healthy men. Therapeutic Drug Monitoring, 11, 176-184.
25. TESTA, B. and JENNER, P., 1981, Inhibitors of cytochrome P-450s and their mechanism of action. Drug Metabolism Reviews, 12, 1-117.
26. THOMAS, P. E., REIK, L. M., RYAN, D. E. and LEVIN, W., 1983, Induction of two immunochemically related rat liver cytochrome P450 isozymes, cytochromes P450c and P450d, by structurally diverse xenobiotics. Journal of Biological Chemistry, 258, 4590-4598.
27. ZOMORODI, K., CARLILE, D. J. and HOUSTON, J. B., 1995, Kinetics of diazepam metabolism in rat hepatic microsomes and hepatocytes and their use in predicting in vivo hepatic clearance. Xenobiotica, 25, 907-916.
28. ZOMORODI, K. and HOUSTON, J. B., 1995, Effect of omeprazole on diazepam disposition in the rat: in vitro and in vivo studies. Pharmaceutical Research, 12, 1642-1646.
29. ZOMORODI, K. and HOUSTON, J. B., 1996, Diazepam-omeprazole inhibition interaction: an in vitro investigation using human liver microsomes. British Journal of Clinical Pharmacology, 42, 157-162.